semaglutide april 2025 When Joshua Hunt (@viajoshhunt) started Ozempic in 2025, the weekly dose of the GLP-1 agonist transformed him. This past March, when he decided to stop, his cravings returned — for FDA Warns on Certain Forms

Hjbjerg Lassen, MD, MSc, PhD and colleagues from CTCPR - Center for Translational Cardiology and Pragmatic Randomized Trials, published in the European Journal of Preventive Cardiology, explored the potential population-level cardiovascular impact of implementing semaglutide (2.4 mg) in Denmark based on the eligibility criteria from the landmark SELECT trial

The injectable drugs have been in shortage since 2022.

But it's still day 1, and we've got a long way to go to achieve our Mission of changing 1B lives by reversing diabetes and solving obesity through nutrition

Weight regulation involves hormones, digestion, and metabolic signaling working together

Our volumizing complex comprised of next generation hyaluronic acid, biomimetic collagen fragments, bakuchiol plus amino acids works synergistically to improve skin impacted by GLP-1 induced facial volume loss and skin texture decline by addressing the appearance of deflation, loose, sagging, crepey skin texture, dehydration, and wrinkles